OTC · Medical - Pharmaceuticals

FusionPharm, Inc. (FSPM) Stock

$0.00 OTC: FSPM Healthcare

FusionPharm, Inc. specializes in the development, manufacturing, and sale of advanced indoor cultivation systems, marketed under its PharmPod brand.

Valuation

MetricValue
Price$0.00
Market Cap$1259
P/E Ratio
P/B Ratio
P/S Ratio
EPS (TTM)$-0.15
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE
ROA-137.69%
ROCE
Gross Margin20.39%
Operating Margin-124.14%
Net Margin-110.72%
Debt/Equity
Current Ratio0.73

Valuation & Return Ratios

MetricValue
PEG Ratio
EV / EBITDA
FCF Yield
Quick Ratio
Interest Coverage
Return 1Y0.00%
Return 3Y0.00%
Return 5Y

Ownership

Insiders Held0.00%
Institutions Held0.02%
Institutions Float Held0.02%
Institutional HolderSharesReport Date
Ascentis Independent Advisors2,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADYXAdynxx, Inc. $0.00 0.00 $581 0.00%
BGMDBG Medicine, Inc. $0.00 0.00 $1137 0.00%
BIMIBIMI International Medical Inc. $0.00 0.00 $1156 0.00%
BNKLBionik Laboratories Corp. $0.00 0.00 $1248 0.00%
CFRXQContraFect Corp. $0.00 0.00 $107 0.00%

About FusionPharm, Inc.

FusionPharm, Inc. specializes in the development, manufacturing, and sale of advanced indoor cultivation systems, marketed under its PharmPod brand. These enclosed growing units are distributed across the United States and cater to a diverse clientele, including commercial businesses, academic institutions, and individual growers, enabling them to cultivate a wide variety of plants. Founded in 1998, the company initially operated as Baby Bee Bright Corp. before adopting its current corporate identity, FusionPharm, Inc., in April 2011. Its operations are headquartered in Commerce City, Colorado.

FusionPharm, Inc. (FSPM) stock trades at $0.00 with a market capitalization of $1259. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, FusionPharm, Inc. generates an operating margin of -124.14%, a net profit margin of -110.72%.

Official website: www.fusionpharminc.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides